v3.25.2
RESTATEMENT
12 Months Ended
Mar. 31, 2025
Accounting Changes and Error Corrections [Abstract]  
RESTATEMENT RESTATEMENT OF UNAUDITED QUARTERLY FINANCIAL STATEMENTS
The unaudited condensed consolidated financial statements for three and nine-months ended December 31, 2024 are being restated for the following.

a.Service contract term - The Company identified that there were inconsistencies in the period used to recognize service and subscription revenue, which is deferred under Topic 606 and recognized ratably over the contractual term of the contract. The Company’s management reviewed and updated the periods over which revenue was being recognized to ensure consistent application for all service contracts invoiced in the fiscal year ended March 31, 2025 and the results have been applied to revenue.

b.Application of Topic 606 related to standalone selling price - The Company also determined that the standalone selling price that was being used for the fiscal year ended March 31, 2025 needed to be updated resulting in an adjustment to revenue. Standalone selling price has now been refreshed for all goods and services sold in a bundled contract under Topic 606, maximizing the use of observable inputs.

The following tables present the impact of the restatement for three and nine-months ended December 31, 2024:
December 31, 2024
As previously reportRestatement adjustmentsReferenceAs restated
Assets
Current assets:
Cash and cash equivalents$20,381 $— $20,381 
Restricted cash222 — 222 
Accounts receivable, net of allowance for credit losses of $99
61,373 — 61,373 
Manufacturing inventories18,861 — 18,861 
Service parts inventories1,884 — 1,884 
Prepaid expenses2,569 — 2,569 
Other current assets8,538 — 8,538 
Total current assets113,828 — — 113,828 
Property and equipment, net 11,268 — 11,268 
Goodwill 12,969 — 12,969 
Intangible assets, net 509 — 509 
Right-of-use assets8,670 — 8,670 
Other long-term assets20,812 — 20,812 
Total assets$168,056 — $168,056 
Liabilities and Stockholders’ Deficit
Current liabilities:
Accounts payable$34,704 — $34,704 
Accrued compensation11,702 — 11,702 
Deferred revenue, current portion69,916 (3,154)
a, b
66,762 
Term debt
98,609 — 98,609 
Revolving credit facility37,500 — 37,500 
Warrant liabilities34,005 — 34,005 
Other accrued liabilities19,108 — 19,108 
Total current liabilities305,544 (3,154)302,390 
Deferred revenue, net of current portion35,350 4,721 
a, b
40,071 
Operating lease liabilities9,067 — 9,067 
Other long-term liabilities13,150 — 13,150 
Total liabilities363,111 1,567 364,678 
Commitments and contingencies
Stockholders' deficit
Preferred stock, 20,000 shares authorized; no shares issued and outstanding
— — — 
Common stock, $0.01 par value; 225,000 shares authorized; 5,307 and 4,792 shares issued and outstanding
53 — 53 
Additional paid-in capital740,521 — 740,521 
Accumulated deficit(933,160)(1,567)
a, b
(934,727)
Accumulated other comprehensive loss(2,469)— (2,469)
Total stockholders’ deficit(195,055)(1,567)(196,622)
Total liabilities and stockholders’ deficit$168,056 — $168,056 
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(in thousands, except per share amounts, unaudited)

FY 2025
Three Months Ended December 31
Nine Months Ended December 31
As previously reportAdjustmentsReferenceAs restatedAs previously reportAdjustmentsReferenceAs restated
Revenue:
   Product$38,610 $24 
b
$38,634 $116,389 $4,176 
b
$120,565 
   Service and subscription31,615 (3,891)
a, b
27,724 90,383 (5,743)
a, b
84,640 
   Royalty2,326 — 2,326 7,592 — 7,592 
      Total revenue72,551 (3,867)68,684 214,364 (1,567)212,797 
Cost of revenue:
   Product30,922 — 30,922 93,251 — 93,251 
   Service and subscription9,874 — 9,874 33,954 — 33,954 
      Total cost of revenue40,796 — 40,796 127,205 — 127,205 
Gross profit31,755 (3,867)27,888 87,159 (1,567)85,592 
Operating expenses:
Sales and marketing12,448 — 12,448 39,321 — 39,321 
General and administrative14,142 — 14,142 49,186 — 49,186 
Research and development7,683 — 7,683 24,255 — 24,255 
Restructuring charges1,342 — 1,342 2,916 — 2,916 
      Total operating expenses35,615 — 35,615 115,678 — 115,678 
Loss from operations(3,860)(3,867)(7,727)(28,519)(1,567)(30,086)
Other income (expense), net967 — 967 (408)— (408)
Interest expense(6,840)— (6,840)(16,761)— (16,761)
Change in fair value of warrant liabilities(61,630)— (61,630)(56,414)— (56,414)
Loss on debt extinguishment— — — (3,003)— (3,003)
      Net loss before income taxes(71,363)(3,867)(75,230)(105,105)(1,567)(106,672)
Income tax provision70 — 70 675 — 675 
Net loss$(71,433)$(3,867)$(75,300)$(105,780)$(1,567)$(107,347)
Net loss per share - basic and diluted
$(14.56)$(0.79)$(15.35)$(21.90)$(0.32)$(22.22)
Weighted average shares - basic and diluted
4,907 — 4,907 4,831 — 4,831 
Net loss$(71,433)$(3,867)$(75,300)$(105,780)$(1,567)$(107,347)
Foreign currency translation adjustments, net(1,077)— (1,077)(276)— (276)
Total comprehensive loss$(72,510)$(3,867)$(76,377)$(106,056)$(1,567)$(107,623)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands, unaudited)
Nine Months Ended December 31, 2024
As previously reportedRestatement adjustmentsReference
As restated
Operating activities
Net loss$(105,780)$(1,567)$(107,347)
  Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization4,440 — 4,440 
Amortization of debt issuance costs3,704 — 3,704 
Non-cash lease expense
1,342 — 1,342 
Loss on debt extinguishment3,003 — 3,003 
Provision for product and service inventories1,165 — 1,165 
Stock-based compensation2,376 — 2,376 
Paid in kind interest3,515 — 3,515 
Change in fair value of warrant liabilities56,408 — 56,408 
Other non-cash(281)— (281)
Changes in assets and liabilities:— — 
Accounts receivable, net6,337 — 6,337 
Manufacturing inventories(2,347)— (2,347)
Service parts inventories7,972 — 7,972 
Prepaid expenses(382)— (382)
Operating lease liabilities
(813)— (813)
Accounts payable 9,406 — 9,406 
Accrued compensation(6,512)— (6,512)
Deferred revenue(11,421)1,567 
a, b
(9,854)
Other current assets1,243 — 1,243 
Other current liabilities6,280 — 6,280 
Net cash used in operating activities(20,345)— (20,345)
Investing activities
Purchases of property and equipment(4,324)— (4,324)
Net cash used in investing activities(4,324)— (4,324)
Financing activities
Borrowings of long-term debt, net of debt issuance costs25,000 — 25,000 
Repayments of long-term debt(14,092)— (14,092)
Borrowings of credit facility311,135 — 311,135 
Repayments of credit facility(302,628)— (302,628)
Net cash provided by financing activities19,415 — 19,415 
Effect of exchange rate changes on cash, cash equivalents and restricted cash(3)— (3)
Net change in cash, cash equivalents and restricted cash (5,257)— (5,257)
Cash, cash equivalents, and restricted cash at beginning of period25,860 — 25,860 
Cash, cash equivalents, and restricted cash at end of period $20,603 $— $20,603 
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the statement of cash flows:
Cash and cash equivalents20,381 — 20,381 
Restricted cash, current222 — 222 
Cash, cash equivalents and restricted cash at the end of period
$20,603 $— $20,603 
Supplemental disclosure of cash flow information
      Cash paid for interest$8,841 $— $8,841 
      Cash paid for income taxes, net$1,798 $— $1,798 
   Non-cash transactions
     Purchases of property and equipment included in accounts payable $88 $— $88 
     Right-of-use assets obtained in exchange for new lease liabilities
$538 $— $538 
     Paid-in-kind interest$3,515 $— $3,515 
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT
(in thousands, unaudited)

Common StockAdditional
Paid-in Capital
Accumulated DeficitAccumulated Other Comprehensive LossTotal Stockholders' Deficit
Three Months EndedSharesAmount
Balance, September 30, 2024, As Revised
4,792 $48 $709,667 $(859,427)$(1,392)$(151,104)
Net loss— — — (75,300)— (75,300)
Foreign currency translation adjustments, net— — — — (1,077)(1,077)
Shares issued under employee incentive plans, net109 (1)— — — 
Warrants exercised related to long-term debt
406 30,119 — — 30,123 
Stock-based compensation— — 736 — — 736 
Balance, December 31, 2024, As Restated
5,307 $53 $740,521 $(934,727)$(2,469)$(196,622)

Common StockAdditional
Paid-in Capital
Accumulated DeficitAccumulated Other Comprehensive LossTotal Stockholders' Deficit
Nine Months EndedSharesAmount
Balance, March 31, 20244,792 $48 $708,027 $(827,380)$(2,193)$(121,498)
Net loss— — — (107,347)— (107,347)
Foreign currency translation adjustments, net— — — — (276)(276)
Shares issued under employee incentive plans, net109 (1)— — — 
Warrants exercised related to long-term debt
406 30,119 — — 30,123 
Stock-based compensation— — 2,376 — — 2,376 
Balance, December 31, 2024 As Restated
5,307 $53 $740,521 $(934,727)$(2,469)$(196,622)